Biological active additive to
Tsitsibon® food
Structure
In 1 capsule soderzhitsyasukhy the extract of a cranberry of North American-260 mg (standardized min. 7% of PATs-A (pro-anthocyanidin of type A), dry extract of leaves of a bearberry of-90 mg (min. 20% of arbutin), vitamin C (ascorbic acid) of-37 mg, dry extract of leaves of an orthosiphon - 37 mg. excipients: microcrystalline cellulose (filler), magnesium stearate, silicon dioxide, magnesium oxide (balling up inhibitor), hydroxide propyl marked cellulose (cover).
Scope:
Цицибон® it is applied to prevention of a recurrence and also as supportive application at complex therapy of infections of urinary tract. Strengthens action of antibiotics. Contributes to urination normalization, reduces risk of repeated exacerbations of chronic cystitis, improves a functional condition of kidneys and uric ways. The complex of biologically active agents which are a part of Tsitsibon® has antimicrobial, anti-inflammatory and diuretic effect. Systematic and prolonged use of Tsitsibon® in cystitis allows to try to obtain longer and high-quality remissions (vyzdorovleniya) with rare aggravations (in a chronic disease) or to prevent a recurrent disease at the cured acute cystitis.
The Tsitsibon® Standardized Cranberry Extract Which Is Part properties, it is developed from a North American red cranberry (Vaccinium Macrocarpon). The North American cranberry has high concentration of pro-anthocyanidins like A or PATs-A which are the active oligomerous final products of a biosynthetic way of metabolism of flavonoids. A number of scientific research (Howell et al., the Phytochemistry magazine 2005) showed that PAC-A, has abhesive activity in relation to bacterial agents. It interferes with adhesion (sticking) of bacteria to the epithelium cells covering urinary tract that does not allow bacteria to be fixed on bladder walls. Also there is a damage of a bacterial cover that interferes with reproduction of causative organisms on the surface of an epithelium of a bladder and urinary tract.
A route of administration and the recommended daily dose
the Adult. On 2 capsules in once a day, washing down with a glass of water. In infections of urinary tract with urodynia and burning during urination, it is necessary to accept Tsitsibon® within, at least, 1 month. If treatment of infections of urinary tract was carried out by antibiotics, it is necessary to accept Tsitsibon® within, at least, 3 weeks after end of a course of antibiotic treatment.
Contraindications
At individual intolerance of components of drug. Reception of Tsitsibon® in the recommended doses does not cause side reactions.
The special
instructions Dietary supplement to food, is not medicine. Do not exceed the recommended dose. The patients accepting warfarin and at the same time the products containing a cranberry or its juice should pay attention to their potentially possible interaction with risk of developing of bleeding.
To Store storage conditions in the dry and cool place. To store out of children's reach.
Expiration date: 3 years.
Not to apply after end of an expiration date.
A form of release
of 30 vegetable capsules in a polyethylene bottle
Tsitsibon® food
Structure
In 1 capsule soderzhitsyasukhy the extract of a cranberry of North American-260 mg (standardized min. 7% of PATs-A (pro-anthocyanidin of type A), dry extract of leaves of a bearberry of-90 mg (min. 20% of arbutin), vitamin C (ascorbic acid) of-37 mg, dry extract of leaves of an orthosiphon - 37 mg. excipients: microcrystalline cellulose (filler), magnesium stearate, silicon dioxide, magnesium oxide (balling up inhibitor), hydroxide propyl marked cellulose (cover).
Scope:
Цицибон® it is applied to prevention of a recurrence and also as supportive application at complex therapy of infections of urinary tract. Strengthens action of antibiotics. Contributes to urination normalization, reduces risk of repeated exacerbations of chronic cystitis, improves a functional condition of kidneys and uric ways. The complex of biologically active agents which are a part of Tsitsibon® has antimicrobial, anti-inflammatory and diuretic effect. Systematic and prolonged use of Tsitsibon® in cystitis allows to try to obtain longer and high-quality remissions (vyzdorovleniya) with rare aggravations (in a chronic disease) or to prevent a recurrent disease at the cured acute cystitis.
The Tsitsibon® Standardized Cranberry Extract Which Is Part properties, it is developed from a North American red cranberry (Vaccinium Macrocarpon). The North American cranberry has high concentration of pro-anthocyanidins like A or PATs-A which are the active oligomerous final products of a biosynthetic way of metabolism of flavonoids. A number of scientific research (Howell et al., the Phytochemistry magazine 2005) showed that PAC-A, has abhesive activity in relation to bacterial agents. It interferes with adhesion (sticking) of bacteria to the epithelium cells covering urinary tract that does not allow bacteria to be fixed on bladder walls. Also there is a damage of a bacterial cover that interferes with reproduction of causative organisms on the surface of an epithelium of a bladder and urinary tract.
A route of administration and the recommended daily dose
the Adult. On 2 capsules in once a day, washing down with a glass of water. In infections of urinary tract with urodynia and burning during urination, it is necessary to accept Tsitsibon® within, at least, 1 month. If treatment of infections of urinary tract was carried out by antibiotics, it is necessary to accept Tsitsibon® within, at least, 3 weeks after end of a course of antibiotic treatment.
Contraindications
At individual intolerance of components of drug. Reception of Tsitsibon® in the recommended doses does not cause side reactions.
The special
instructions Dietary supplement to food, is not medicine. Do not exceed the recommended dose. The patients accepting warfarin and at the same time the products containing a cranberry or its juice should pay attention to their potentially possible interaction with risk of developing of bleeding.
To Store storage conditions in the dry and cool place. To store out of children's reach.
Expiration date: 3 years.
Not to apply after end of an expiration date.
A form of release
of 30 vegetable capsules in a polyethylene bottle
Related Products
Avara Pharmaceutical Technologies Inc. (USA)
Vezomni 6 mg / 0.4 mg 30s modified release tablets
$85.00